Medtrade Products Ltd is delighted to announce that it has entered into an exclusive agreement with Laubscher & Co AG to distribute the revolutionary CELOX™ PPH Uterine Haemostatic Tamponade in Switzerland. CELOX PPH offers a unique, CE-certified solution for uterine postpartum haemorrhage (PPH), and Laubscher’s network of Swiss hospitals and clinics will help more…
Medtrade Products Ltd is delighted to announce that it has entered into an exclusive agreement with Dahlhausen® Medizintechnik to distribute the revolutionary CELOX™ PPH Uterine Haemostatic Tamponade throughout Austria and Germany. CELOX PPH offers a unique, CE-certified solution for uterine postpartum haemorrhage (PPH), and Dahlhausen Medizintechnik’s extensive network will help more clinicians to access this…
Medtrade Products Ltd is pleased to announce CE certification for its CELOX™ PPH Uterine Haemostatic Tamponade, a significant and state-of-the-art innovation that provides rapid and effective control of postpartum bleeding, a prevalent and severe complication of childbirth. Gaining accreditation for this game-changing device is a significant medical milestone in the field of obstetrics. Postpartum haemorrhage (PPH)…
Russ Mably, our CEO of Medtrade and Celox Medical products, attended an interview on Cat Radio to proudly discuss the highlights of Medtrade and the support provided to the crisis in Ukraine. Medtrade mobilised rapidly reacting to the situation in Ukraine and is manufacturing around the clock to help support the people of Ukraine. We…
New York, May 6, 2022 – As the war in Ukraine enters its third month, journalists facing increased risks in their daily reporting will receive lifesaving medical supplies through a new partnership between the Committee to Protect Journalists and the medical device company Medtrade, the manufacturer of CELOX Hemostatic Technology. The medical supplies, designed to stop hemorrhaging within…
Medtrade Products Ltd are proud to announce the success of receiving the MDR certification for the CELOX CE range of devices alongside MDR Quality Management system certification from BSI. The EU MDR is a medical device regulation that affects all medical devices placed in the European market. Medtrade the parent company of Celox Medical has been…
Medtrade Products Ltd are proud to announce the successful award of an innovation and research project from the Medical Technology Enterprise Consortium (MTEC NCH – MTEC (mtec-sc.org). Despite fierce competition from numerous different companies, the U.S. Army Medical Material Development Activity (USAMMDA) selected Medtrade Products Ltd to create a product designed for military medical use, specifically…
Despite significant developments in scientific understanding and technology, hemorrhage remains the leading cause of preventable trauma related deaths in civilian life and on the battlefield.1-3 The challenges medics face when treating a patient is being unaware of the patients internal conditions through, for example, the use of blood thinners. Another challenge is the patient’s external…
The conflict in Iraq, that began in 2003 and ran until 2011, is arguably one of the most divisive and controversial conflicts in recent memory. No matter how history ultimately looks upon the war, there are several lessons we can take from it, particularly in terms of trauma care in the battlefield. Here, Celox Medical’s…
Emergency wound care and haemostatic agent specialist Celox™ Medical has appointed SP Services as the sole distributor for its range of products in the United Kingdom. Clients nationwide will benefit from faster and more effective supply across the whole range of Celox haemostats. This includes Celox’s latest technology, the Rapid haemostatic gauze. SP Services is…
© Medtrade Products Ltd 2023
This website uses Cookies to improve your browsing experience. View Cookies Policy
I'm fine with this
